Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Leaming Nancy, Director. Insider active across 2 companies, notably BIOGEN INC.. Aggregated, 2 reports have been published. History available since 1 July 2021. The latest transaction was disclosed on 1 July 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Nancy Leaming is a Director at BIOGEN INC. In this role, she participates in the governance of the company and strategic decision-making. Leaming brings valuable expertise to the board through her experience in the biopharmaceutical sector. Her commitment to innovation and corporate responsibility is essential in guiding BIOGEN's initiatives. She collaborates with other board members to ensure the strategic direction of the company.